アブストラクト
| Title | 糖尿病性ケトアシドーシス |
|---|---|
| Subtitle | 特集 実践 - 小児の輸液 各病態における輸液の考え方 : 内分泌・代謝疾患 |
| Authors | 峯佑介*, 浦上達彦 |
| Authors (kana) | |
| Organization | *日本大学病院小児科 |
| Journal | 小児内科 |
| Volume | 53 |
| Number | 4 |
| Page | 593-598 |
| Year/Month | 2021 / 4 |
| Article | 報告 |
| Publisher | 東京医学社 |
| Abstract | 「Key Points」(1)DKAはいかに早く診断し治療を開始するかが重症化予防のカギとなる. (2)DKAの死因の60〜90%は脳浮腫であり, 急激な血管内の浸透圧変化に起因した脳浮腫を起こさないよう, 血糖降下速度に注意を払いながら治療を進めることが重要となる. (3)心電図異常を起こさないように電解質濃度を測定しながら, 電解質の補正を行う必要がある. (4)DKA再発の予防のためには患者教育を行う必要がある. |
| Practice | 臨床医学：内科系 |
| Keywords |
- 全文ダウンロード： 従量制、基本料金制の方共に1,023円(税込) です。
参考文献
- 1) Morgan E, Black CR, Abid N, et al : Mortality in type 1 diabetes diagnosed in childhood in North-ern Ireland during 1989-2012 : A population-based cohort study. Pediatr Diabetes 19 : 166-170, 2018
- 2) Cox K, Cocchi MN, Salciccioli JD, et al : Preva-lence and significance of lactic acidosis in dia-betic ketoacidosis. J Crit Care 27 : 132-137, 2012
- 3) Urakami T, Habu M, Suzuki J : Diabetic ketoacido-sis and severe hypoglycemia in management of type 1 diabetes during 2003-2013. Pediatr Int 56 : 940, 2014
- 4) Ogawa W, Sakaguchi K : Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors : possi-ble mechanism and contributing factors. J Diabe-tes Investig 7 : 135-138, 2016
- 5) Dunger DB, Sperling MA, Acerini CL, et al : ESPE/LWPES consensus statement on diabetic ketoaci-dosis in children and adolescents. Arch Dis Child 89 : 188-194, 2004
残りの9件を表示する
- 6) Lokulo-Sodipe K, Moon RJ, Edge JA, et al : Identi-fying targets to reduce the incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes in the UK. Arch Dis Child 99 : 438-442, 2014
- 7) Sundaram PCB, Day E, Kirk JMW : Delayed diag-nosis in type 1 diabetes mellitus. Arch Dis Child 94 : 151-152, 2009
- 8) Pawlowicz M, Brikholz D, Niedzwiecki M, et al : Difficulties or mistakes in diagnosing type 1 dia-betes in children?--demographic factors influ-encing delayed diagonosis. Pediatr Diabetes 10 : 542-549, 2009
- 9) Wolfsdorf JI, Glasser N, Agus M, et al : ISPAD Clin-ical Practice Consensus Guidelines 2018 : Dia-betic ketoacidosis and the hyperglycemic hyper-osmolar state. Pediatr Diabetes 19 : 155-177, 2018
- 10) Glaser N, Barnett P, McCaslin I, et al : Risk factor for cerebral edema in children with diabetic keto-acidosis. The Pediatric Emergency Medicine Col-laborative Research Committee of the American Academy of Pediatrics. N Engl J Med 344 : 264-269, 2001
- 11) Al Hanshi S, Shann F : Insulin infused at 0.05 ver-sus 0.1 units/kg/hr in children admitted to inten-sive care with diabetic ketoacidosis. Pediatr Crit Care Med 12 : 137-140, 2011
- 12) Edge JA, Jakes RW, Roy Y, et al : The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 49 : 2002-2009, 2006
- 13) Fisher JN, Kitabchi AE : A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 57 : 177-180, 1983
- 14) Harrison VS, Rustico S, Palladino AA, et al : Glargine co-administration with intravenous insu-lin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimen. Pediatr Diabetes 18 : 742-748, 2017
